Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
ABBOTT LABORATORIES | EXECUTIVE VICE PRESIDENT | Common shares without par value | 61.5K | $6.53M | $106.25 | May 7, 2024 | Direct |
ABBOTT LABORATORIES | EXECUTIVE VICE PRESIDENT | Option (right to buy) | 64.8K | Feb 21, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ABT | ABBOTT LABORATORIES | May 7, 2024 | 1 | -$2.43M | 4 | May 8, 2024 | EXECUTIVE VICE PRESIDENT |
ABT | ABBOTT LABORATORIES | Feb 29, 2024 | 2 | -$1M | 4 | Mar 4, 2024 | EXECUTIVE VICE PRESIDENT |
ABT | ABBOTT LABORATORIES | Feb 21, 2024 | 2 | $0 | 4 | Feb 23, 2024 | EXECUTIVE VICE PRESIDENT |
ABT | ABBOTT LABORATORIES | Feb 28, 2023 | 2 | -$856K | 4 | Mar 2, 2023 | EXECUTIVE VICE PRESIDENT |
ABT | ABBOTT LABORATORIES | Feb 17, 2023 | 2 | $0 | 4 | Feb 22, 2023 | EXECUTIVE VICE PRESIDENT |
ABT | ABBOTT LABORATORIES | Jun 10, 2022 | 2 | -$2.53M | 4 | Jun 14, 2022 | EXECUTIVE VICE PRESIDENT |
ABT | ABBOTT LABORATORIES | Feb 28, 2022 | 2 | -$744K | 4 | Mar 2, 2022 | EXECUTIVE VICE PRESIDENT |
ABT | ABBOTT LABORATORIES | Feb 18, 2022 | 2 | $0 | 4 | Feb 23, 2022 | EXECUTIVE VICE PRESIDENT |
ABT | ABBOTT LABORATORIES | Jun 10, 2021 | 1 | -$314K | 4 | Jun 11, 2021 | EXECUTIVE VICE PRESIDENT |